Cleared Special

Cystoject Syringe Lever

K203321 · Urogen Pharma, Ltd. · Gastroenterology & Urology
Dec 2020
Decision
27d
Days
Class 2
Risk

About This 510(k) Submission

K203321 is an FDA 510(k) clearance for the Cystoject Syringe Lever, a Piston Syringe Lever (Class II — Special Controls, product code QBL), submitted by Urogen Pharma, Ltd. (Ra'Anana, IL). The FDA issued a Cleared decision on December 9, 2020, 27 days after receiving the submission on November 12, 2020. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K203321 FDA.gov
FDA Decision Cleared SESE
Date Received November 12, 2020
Decision Date December 09, 2020
Days to Decision 27 days
Submission Type Special
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code QBL — Piston Syringe Lever
Device Class Class II — Special Controls
CFR Regulation 21 CFR 880.5860
Definition Controlled Compression Of A Piston Syringe